Ken Fisher's BBIO Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 232,401 shares of BridgeBio Pharma, Inc. (BBIO) worth $17.78 M, representing 0.01% of the portfolio. First purchased in 2021-Q3, this short-term holding has been held for 4 quarters.
Based on 13F filings, Ken Fisher has maintained this position in BBIO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 232,401 shares. Largest reduction occurred in Q1 2022, reducing 763,531 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's BridgeBio Pharma (BBIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly BridgeBio Pharma (BBIO) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +232,401 | New Buy | 232,401 | $76.49 |
| Q1 2022 | -763,531 | Sold Out | 0 | $0.00 |
| Q4 2021 | +194,266 | Add 34.13% | 763,531 | $16.68 |
| Q3 2021 | +569,265 | New Buy | 569,265 | $46.87 |
Ken Fisher's BridgeBio Pharma Investment FAQs
Ken Fisher first purchased BridgeBio Pharma, Inc. (BBIO) in Q3 2021, acquiring 569,265 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held BridgeBio Pharma, Inc. (BBIO) for 4 quarters since Q3 2021.
Ken Fisher's largest addition to BridgeBio Pharma, Inc. (BBIO) was in Q3 2021, adding 569,265 shares worth $26.68 M.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 232,401 shares of BridgeBio Pharma, Inc. (BBIO), valued at approximately $17.78 M.
As of the Q4 2025 filing, BridgeBio Pharma, Inc. (BBIO) represents approximately 0.01% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in BridgeBio Pharma, Inc. (BBIO) was 763,531 shares, as reported at the end of Q4 2021.